City of Hope

City of Hope Orange County is transforming cancer care delivery in the nation’s sixth largest county. With the 2025 opening of Orange County’s only cancer specialty hospital, City of Hope is advancing a national model for cancer research and treatment on its 72-acre research campus. The visionary initiative completes the most advanced, integrated cancer care network in the region, bringing more cancer-focused expertise, breakthrough acute and outpatient care, novel clinical trials and groundbreaking technology to a community with pressing needs. The hospital is seamlessly connected to City of Hope Orange County Lennar Foundation Cancer Center, ensuring uninterrupted care for each patient’s needs (low acuity or complex.)

The Genitourinary (GU) Medical Oncology Division runs a dedicated clinic and full inpatient consult service. This position is a unique opportunity to be part of a high-level oncology practice and work in a multidisciplinary medical group with an emphasis on collegiality and teamwork. Click here for more information about Genitourinary Cancer Care in Orange County, the Los Angeles-Area Genitourinary Cancer Program, or The Department of Medical Oncology at City of Hope.

The Division consists of full-time faculty between the Duarte and Irvine campuses, advanced practice providers, and a group of highly motivated and efficient nurses and ancillary staff. This position will report into Tanya Barauskas Dorff, M.D., F.A.S.C.O., Division Chief of Genitourinary Medical Oncology and Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope National Medical Center. Dr. Dorff is an internationally recognized expert in novel therapies and immunotherapy, overseeing one of the largest GU cancer clinical trial portfolios in the nation. She is a physician-scholar with more than 75 publications in peer-reviewed journals such as Cancer, Lancet Oncology and Journal of Clinical Oncology, and she serves as a member of the National Comprehensive Cancer Network’s Prostate Cancer Guidelines Committee and the co-chair for prostate cancer on the SWOG genitourinary committee.

Highlights:

• Provide multidisciplinary care for patients with GU malignancies, including clinical trial enrollment, mentorship of junior faculty, and contributions to research and scholarly activities while delivering compassionate, patient-centered care.
• Support the growth of the Genitourinary Cancer Program, including prostate, bladder, kidney, testicular, and other GU malignancies, as well as Early Therapeutics/Phase I clinical research.
• Collaborate closely with Urology, Radiation Oncology, and other multidisciplinary teams to advance integrated care models, clinical program development, and research initiatives across Orange County.
• Primary clinical responsibilities will focus on the care of patients with genitourinary cancers.
• State-of-the-art facilities: 73 bed hospital, 4 operating room suites, 8 bed ICU
  
  

Position Benefits:

• Excellent benefits package, including a generous retirement contribution plan
• Relocation assistance may be available
• Base Salary Range: $400,000 - $550,000 (Associate to Full Professor level). The range listed is exclusively for base compensation for full-time employment and does not include incentive compensation or benefits. Actual compensation will be adjusted for experience, training, hospital/community need and other factors.
  
  

Benefits information: City of Hope Medical Group Benefits

City of Hope’s comprehensive cancer center extends far beyond traditional clinical care. Its integrated model combines world-class research, education, and patient-centered services to address the full spectrum of patient needs. This includes:

• Access to a robust pipeline of laboratory discoveries rapidly translated into clinical applications
• Comprehensive survivorship programs and supportive care services
• Integrated psychosocial, nutritional, and rehabilitation support
• A strong culture of innovation, collaboration, and mission-driven care
  
  

This “beyond the clinic” approach ensures that patients receive not only cutting-edge treatment but also comprehensive, compassionate care throughout every stage of their cancer journey.

About City Of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is top ranked in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

City of Hope is an equal opportunity employer.

Qualifications:

• Expertise in genitourinary oncology, with demonstrated excellence in the care of patients with prostate, bladder, kidney, testicular, and other GU malignancies
• Academic physician at the late Assistant, Associate, or Full Professor level with a strong commitment to clinical excellence, research, and program growth
• 3–5+ years of GU oncology experience, with a track record of growing a clinical practice and participating in disease-focused clinical and research initiatives. Clinical trials experience preferred
• Proven ability to mentor physicians, APPs, and trainees, and to contribute to clinical research, scholarly activities, and program development
• Leadership experience collaborating with multidisciplinary teams, including Urology, Radiation Oncology, Pathology, Radiology, and Supportive Care, to advance a comprehensive GU Cancer Program
• Demonstrated success in expanding clinical services, enhancing patient access to innovative therapies and clinical trials, and delivering coordinated, high-quality cancer care
• Eligible to obtain or currently hold an active CA medical license
• ABIM/Medical Oncology Board Certified/Eligible status